Przemyslaw P. McEwan, PhD

Dr. Przemyslaw P. McEwan is a science law clerk and registered patent agent in the firm’s Business Law department and a member of its Intellectual Property group. He joined Goodwin in 2023.

Peter assists clients with patent preparation, patent prosecution, patentability analysis, freedom-to-operate analysis, intellectual property due diligence, and general intellectual property counseling. Peter has experience in managing patent portfolios and developing domestic and foreign patent prosecution strategies. Prior to joining Goodwin, Peter was a Patent Agent at a large national firm.

Prior to joining Goodwin, Peter worked as a Patent Agent at a large national firm. Peter conducted his doctoral research at Rutgers University, where he investigated molecular mechanisms of traumatic brain injuries. Following graduate school, Peter conducted his post-doctoral research at University of Pennsylvania, where he investigated the mechanisms of white matter conductivity changes following concussions utilizing small and large animal models. Peter is currently an evening JD student at the Beasley School of Law at Temple University and expects to graduate in 2025.

In graduate school, Peter received a number of fellowships, including National Science Foundation Innovation Corps fellowship, New Jersey Commission for Spinal Cord Research fellowship, New Jersey Commission on Brain Injury Research fellowship, National Institutes of Health under Ruth L. Kirschstein fellowship in Biotechnology, and Anne B. and James B. Letham fellowship.

Co-Author, “Federal Circuit Continues to Dismantle Diagnostic Patents,” Troutman Pepper, August 4, 2022